Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://macieaphb871437.life3dblog.com/35087233/retatrutide-a-promising-new-treatment-for-obesity